2026: Science's Inflection Point Reshapes Economies

Mid-2026 marks a pivotal convergence in biotech, diagnostics, energy, and computing, transitioning lab proofs to commercial realities. This systemic shift promises to compress R&D timelines, decentralize manufacturing, and accelerate energy transitions, forcing rapid policy adaptations amid geopolitical tech races. Economic stakes exceed trillions in reallocated capital.